Clinical trials
Phase 2/3 Uterine Cervical Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2018 | 3 |
| 2020 | 1 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 6 |
| Completed | 3 |
| Unknown status | 3 |
| Enrolling by invitation | 1 |
| Not yet recruiting | 1 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bio-Thera Solutions | 1 |
| Christina Ruhlmann | 1 |
| Instituto Nacional de Salud Publica, Mexico | 1 |
| L & L Bio Co., Ltd., Ningbo, China | 1 |
| Makerere University | 1 |
| Mei Shi | 1 |
| N.N. Alexandrov National Cancer Centre | 1 |
| Nanjing Medical University | 1 |
| National Taiwan University Hospital | 1 |
| Qilu Pharmaceutical Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Uterine Cervical Neoplasms | 16 |
| Head and Neck Neoplasms | 2 |
| Lung Neoplasms | 2 |
| Ovarian Neoplasms | 2 |
| Breast Neoplasms | 1 |
| Carcinoma | 1 |
| Carcinoma, Hepatocellular | 1 |
| Carcinoma, Transitional Cell | 1 |
| Cholangiocarcinoma | 1 |
| Colonic Neoplasms | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.